We expect AbbVie ABBV to beat expectations when it reports second-quarter 2021 results on Jul 30, before market open. In the last reported quarter, the company delivered an earnings surprise of 6.50%.
AbbVie Inc. stock fell 6.2% after a 52-week high despite strong Q2 earnings; Rinvoq and Elahere sales surged. Click for this ...
Goldman Sachs went through AbbVie’s numbers ahead of Friday’s report, and what it found has shifted how Wall Street reads the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results